Gene · 353376
Papers1,547
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
41 to 60 of 1,547
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Epigallocatechin-3-Gallate and Genistein for Decreasing Gut Dysbiosis, Inhibiting Inflammasomes, and Aiding Autophagy in Alzheimer's Disease. | Brain Sci | 2024 | 38275516 | PubTator, text mining | PubMed |
| Damage-Associated Molecular Patterns, a Class of Potential Psoriasis Drug Targets. | Int J Mol Sci | 2024 | 38255845 | PubTator, text mining | PubMed |
| Acute Kidney Injury: Definition, Management, and Promising Therapeutic Target. | Cureus | 2023 | 38283512 | PubTator, text mining | PubMed |
| Enhancing TB Vaccine Efficacy: Current Progress on Vaccines, Adjuvants and Immunization Strategies. | Vaccines (Basel) | 2023 | 38250851 | PubTator, text mining | PubMed |
| Mitochondrial Reactive Oxygen Species in TRIF-Dependent Toll-like Receptor 3 Signaling in Bronchial Epithelial Cells against Viral Infection. | Int J Mol Sci | 2023 | 38203397 | PubTator, text mining | PubMed |
| Sox10-Deficient Drug-Resistant Melanoma Cells Are Refractory to Oncolytic RNA Viruses. | Cells | 2023 | 38201278 | PubTator, text mining | PubMed |
| Immunoinformatics-aided rational design of a multi-epitope vaccine targeting feline infectious peritonitis virus. | Front Vet Sci | 2023 | 38192725 | PubTator, text mining | PubMed |
| TLR agonists as vaccine adjuvants in the prevention of viral infections: an overview. | Front Microbiol | 2023 | 38179453 | PubTator, text mining | PubMed |
| Neurosteroid [3α,5α]-3-hydroxy-pregnan-20-one enhances IL-10 production via endosomal TRIF-dependent TLR4 signaling pathway. | Front Endocrinol (Lausanne) | 2023 | 38179300 | PubTator, text mining | PubMed |
| TRAM deletion attenuates monocyte exhaustion and alleviates sepsis severity. | Front Immunol | 2023 | 38162637 | PubTator, text mining | PubMed |
OncoTherad® (MRB-CFI-1) Nanoimmunotherapy: A Promising Strategy to Treat Bacillus Calmette-Guérin-Unresponsive Non-Muscle-Invasive Bladder Cancer: Crosstalk among T-Cell CX3CR1, Immune Checkpoints, and the Toll-Like Receptor 4 Signaling Pathway. | Int J Mol Sci | 2023 | 38139364 | PubTator, text mining | PubMed |
| Antiviral Activity of Zinc Finger Antiviral Protein (ZAP) in Different Virus Families. | Pathogens | 2023 | 38133344 | PubTator, text mining | PubMed |
| Hyperactive Rac stimulates cannibalism of living target cells and enhances CAR-M-mediated cancer cell killing. | Proc Natl Acad Sci U S A | 2023 | 38109551 | PubTator, text mining | PubMed |
| Exploring the immune interactions between Oncomelania hupensis and Schistosoma japonicum, with a cross-comparison of immunological research progress in other intermediate host snails. | Parasit Vectors | 2023 | 38093363 | PubTator, text mining | PubMed |
| Shedding light on the molecular and regulatory mechanisms of TLR4 signaling in endothelial cells under physiological and inflamed conditions. | Front Immunol | 2023 | 38077393 | PubTator, text mining | PubMed |
| Implications of empirical administration of caspofungin in COVID-19 complicated fungal infections. | Front Cell Infect Microbiol | 2023 | 38076460 | PubTator, text mining | PubMed |
| Small molecule modulators of immune pattern recognition receptors. | RSC Chem Biol | 2023 | 38033733 | PubTator, text mining | PubMed |
| Problems with studying directional natural selection in humans. | Vavilovskii Zhurnal Genet Selektsii | 2023 | 38023807 | PubTator, text mining | PubMed |
| A novel necroptosis signature for predicting survival in lung adenocarcinoma. | BMC Med Genomics | 2023 | 38017445 | PubTator, text mining | PubMed |
| Myristoylated, alanine-rich C-kinase substrate (MARCKS) regulates toll-like receptor 4 signaling in macrophages. | Sci Rep | 2023 | 37949888 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/353376/papers?page=3